West Pharmaceutical (WST) Enters Drug Containment Tech. Evaluation Agreement with Amgen (AMGN)

Article Stock Quotes (2) Comments (0)

West Pharmaceutical Services, Inc. (NYSE: WST), announced an agreement with Amgen Inc. (Nasdaq: AMGN), a biotechnology pioneer and one of the world's leading independent biotechnology companies, to evaluate Daikyo Crystal Zenith technologies for drug containment.

These technologies were developed over many years by West's partner, Daikyo Seiko, Ltd., and are based on a polymeric container, utilizing elastomeric components with Flurotec barrier film, and provided in a sterile, validated, ready-to-fill format.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• Cytokinetics (CYTK) ATOMIC-AHF Results to Be Presented at ESC Congress 2013 (AMGN)
• MasterCard (MA), Western Union (WU) Launch Dedicated Int'l Payments Service for Business
• Sarepta Therapeutics (SRPT) Says Eteplirsen Demonstrates a Continued Benefit on Walking Test Through 84 Weeks

Create E-mail Alert Related Categories

Corporate News

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?